Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_provenance.
- NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_provenance.
- NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_assertion evidence source_evidence_literature NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_provenance.
- NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_assertion SIO_000772 23798432 NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_provenance.
- NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_assertion wasDerivedFrom befree-2016 NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_provenance.
- NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_assertion wasGeneratedBy ECO_0000203 NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_provenance.
- befree-2016 importedOn "2016-02-19" NP1088725.RAw4vvwGGEDg6cZph9xwLMU-CZOCdNe35c9m_xKxcFcQI130_provenance.